{"id":100409,"date":"2020-01-02T14:04:45","date_gmt":"2020-01-02T22:04:45","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2020\/01\/novel-dementia-vaccine-on-track-for-human-trials-within-two-years"},"modified":"2020-01-02T14:04:45","modified_gmt":"2020-01-02T22:04:45","slug":"novel-dementia-vaccine-on-track-for-human-trials-within-two-years","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2020\/01\/novel-dementia-vaccine-on-track-for-human-trials-within-two-years","title":{"rendered":"Novel dementia vaccine on track for human trials within two years"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/novel-dementia-vaccine-on-track-for-human-trials-within-two-years2.jpg\"><\/a><\/p>\n<p>A newly published study has described the successful results in mice of a novel vaccine designed to prevent neurodegeneration associated with Alzheimer\u2019s disease. The researchers suggest this \u201cdementia vaccine\u201d is now ready for human trials, and if successful could become the \u201cbreakthrough of the next decade.\u201d<\/p>\n<p>The new study, led by the Institute for Molecular Medicine and University of California, Irvine, describes the effect of a vaccine designed to generate antibodies that both prevent, and remove, the aggregation of amyloid and tau proteins in the brain. The accumulation of these two proteins is thought to be the primary pathological cause of neurodegeneration associated with Alzheimer\u2019s disease.<\/p>\n<p>The research revealed the vaccine led to significant decreases in both tau and amyloid accumulation in the brains of bigenic mice engineered to exhibit aggregations of these toxic proteins. Many prior failed Alzheimer\u2019s treatments over the past few years have focused individually on either amyloid or tau protein reductions, but growing evidence suggests a synergistic relationship between the two toxic proteins may be driving neurodegeneration. Hence the hypothesis a combination therapy may be the most effective way to prevent this kind of dementia.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A newly published study has described the successful results in mice of a novel vaccine designed to prevent neurodegeneration associated with Alzheimer\u2019s disease. The researchers suggest this \u201cdementia vaccine\u201d is now ready for human trials, and if successful could become the \u201cbreakthrough of the next decade.\u201d The new study, led by the Institute for Molecular [\u2026]<\/p>\n","protected":false},"author":542,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1902,11,47],"tags":[],"class_list":["post-100409","post","type-post","status-publish","format-standard","hentry","category-bioengineering","category-biotech-medical","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/100409","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/542"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=100409"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/100409\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=100409"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=100409"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=100409"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}